Spectrum, The Personality Disorder Service for Victoria, Melbourne, VIC, Australia.
Med J Aust. 2013 Sep 16;199(6 Suppl):S24-7. doi: 10.5694/mja12.10474.
Borderline personality disorder (BPD) is a serious mental illness characterised by dysregulation of emotions and impulses, an unstable sense of self, and difficulties in interpersonal relationships, often accompanied by suicidal and self-harming behaviour. Major depressive disorder (MDD) commonly co-occurs with BPD. Patients with BPD often present with depressive symptoms. It can be difficult to distinguish between BPD and MDD, especially when the two disorders co-occur. Research is needed to clarify the commonalities and differences between BPD and MDD, and BPD and rapid-cycling bipolar disorder. When MDD and BPD co-occur, both conditions should be treated concurrently. MDD co-occurring with BPD does not respond as well to antidepressant medication as MDD in the absence of BPD. MDD is not a significant predictor of outcome for BPD, but BPD is a significant predictor of outcome for MDD. Treatment of BPD with specific psychotherapies tends to result in remission of co-occurring MDD. Empirically validated psychotherapies for BPD share common features that are applicable in all treatment settings where patients with BPD are likely to present, including primary care. Methodologically sound research is required to examine the effectiveness of medications for treatment of MDD co-occurring with BPD.
边缘型人格障碍(BPD)是一种严重的精神疾病,其特征为情绪和冲动失调、自我不稳定以及人际关系困难,通常伴有自杀和自残行为。重性抑郁障碍(MDD)常与 BPD 共病。BPD 患者常出现抑郁症状。区分 BPD 和 MDD 较为困难,尤其是当两种障碍共病时。需要研究来阐明 BPD 和 MDD、BPD 和快速循环双相障碍之间的共性和差异。当 MDD 和 BPD 共病时,应同时治疗两种疾病。与不存在 BPD 的 MDD 相比,MDD 共病 BPD 时对抗抑郁药物的反应较差。MDD 不是 BPD 结局的重要预测因素,但 BPD 是 MDD 结局的重要预测因素。针对 BPD 的特定心理治疗往往会导致共病 MDD 的缓解。针对 BPD 的经实证验证的心理治疗具有共同特征,适用于 BPD 患者可能就诊的所有治疗环境,包括初级保健。需要进行方法学严谨的研究来检验针对 BPD 共病 MDD 的药物治疗的有效性。